Peptides Codex
Home
GnRH agonist (nonapeptide analog)

Buserelin

Buserelin is a synthetic GnRH agonist peptide used to suppress sex-hormone production in hormone-dependent conditions. It is an approved prescription medicine for prostate cancer, premenopausal breast cancer, and endometriosis, and it is used in assisted reproduction protocols. This page is educational and is not medical advice.

By The Peptides Codex Editorial TeamReviewed July 10, 2026
Length
9 aa
Class
GnRH agonist (nonapeptide analog)
Function
Gonadotropin-releasing hormone receptor agonist
Context
Approved medicine for prostate cancer, premenopausal breast cancer, endometriosis, and use in assisted reproduction (prescription)

Available as injection and nasal spray — a versatile GnRH agonist in hormone-dependent conditions.

Also known as: Suprefact · GnRH agonist

Part of the Foundational & therapeutic peptides cluster

Overview

Buserelin is a synthetic GnRH agonist peptide used to suppress sex-hormone production in hormone-dependent conditions. It is an approved prescription medicine for prostate cancer, premenopausal breast cancer, and endometriosis, and it is used in assisted reproduction protocols. This page is educational and is not medical advice.

Source & context

Biological / chemical source: Synthetic GnRH analog

Primary research or clinical context: Approved medicine for prostate cancer, premenopausal breast cancer, endometriosis, and use in assisted reproduction (prescription)

Routes of administration

Buserelin is notable for being available both as a subcutaneous injection and an intranasal spray. The nasal route illustrates how peptide drugs can sometimes reach the circulation across mucosal surfaces, though bioavailability is lower than by injection.

Role in IVF

In assisted reproduction, GnRH agonists like buserelin are used to control the timing of ovulation by first suppressing endogenous gonadotropin surges. This lets clinicians coordinate ovarian stimulation more predictably.

FAQ about Buserelin

What is Buserelin?+

Buserelin is a synthetic GnRH agonist peptide used to suppress sex-hormone production in hormone-dependent conditions. It is an approved prescription medicine for prostate cancer, premenopausal breast cancer, and endometriosis, and it is used in assisted reproduction protocols. This page is educational and is not medical advice.

Is Buserelin an approved medicine?+

Buserelin: Approved medicine for prostate cancer, premenopausal breast cancer, endometriosis, and use in assisted reproduction (prescription). Always follow licensed medical guidance for approved products.

What is the typical length of Buserelin?+

Buserelin is commonly described as approximately 9 amino acids (GnRH agonist (nonapeptide analog)).

Related peptides

References & further reading

  1. 1.Wikipedia — Buserelin
  2. 2.PubChem — compound summary for Buserelin (CID 50225)
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Buserelin educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.